Document is current

Any future updates will be listed below

A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome

Crossref DOI link: https://doi.org/10.1007/BF03401383

Published Online: 2015-01-01

Published Print: 2015-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark